Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation

Mengxue Zhang, Bowen Wang, Go Urabe, Yitao Huang, Jorge Plutzky, K. Craig Kent, Lian-Wang Guo
doi: https://doi.org/10.1101/509414
Mengxue Zhang
1Department of Surgery and Department of Physiology & Cell Biology, College of Medicine; Davis Heart and Lung Research Institute, Wexner Medical Center. The Ohio State University, Columbus, OH 43210, USA.
2Cellular and Molecular Pathology graduate program, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bowen Wang
3Department of Surgery, College of Medicine; Davis Heart and Lung Research Institute, Wexner Medical Center. The Ohio State University, Columbus, OH 43210, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Go Urabe
1Department of Surgery and Department of Physiology & Cell Biology, College of Medicine; Davis Heart and Lung Research Institute, Wexner Medical Center. The Ohio State University, Columbus, OH 43210, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yitao Huang
1Department of Surgery and Department of Physiology & Cell Biology, College of Medicine; Davis Heart and Lung Research Institute, Wexner Medical Center. The Ohio State University, Columbus, OH 43210, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Plutzky
4Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Craig Kent
3Department of Surgery, College of Medicine; Davis Heart and Lung Research Institute, Wexner Medical Center. The Ohio State University, Columbus, OH 43210, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lian-Wang Guo
1Department of Surgery and Department of Physiology & Cell Biology, College of Medicine; Davis Heart and Lung Research Institute, Wexner Medical Center. The Ohio State University, Columbus, OH 43210, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lianwang.guo@osumc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Background Vein-graft bypass is commonly performed to overcome atherosclerosis but is limited by high failure rates, principally due to neointimal wall thickening. Recent studies reveal that endothelial-mesenchymal transition (EndoMT) is critical for vein-graft neointima formation. BETs are a family of Bromo/ExtraTerminal domains-containing epigenetic reader proteins (BRD2, BRD3, BRD4). They bind acetylated histones through their unique tandem bromodomains (BD1, BD2), facilitating transcriptional complex formation and cell-state transitions. The role for BETs, including individual BRDs and their unique BDs, is not well understood in EndoMT and neointimal formation.

Methods and Results Repression of BRD4 expression abrogated TGFβ1-induced EndoMT, with greater effects than BRD2 or BRD3 knockdown. An inhibitor selective for BD2 in all BETs, but not that for BD1, blocked EndoMT. Moreover, expression of a dominant-negative BRD4-specific BD2 fully abolished EndoMT. Concordantly, BRD4 knockdown repressed TGFβ1-stimulated increase of ZEB1 protein – a transcription factor integral in EndoMT. In vivo, lentiviral gene transfer of either BRD4 shRNA or dominant negative BRD4-specific BD2 mitigated neointimal development in rat jugular veins grafted to carotid arteries.

Conclusions Our data reveal the BD2 domain of BRD4 as a determinant driving EndoMT in vitro and neointimal formation in vivo. These findings provide new insight into BET biology, while offering prospects of specific BET domain targeting as an approach to limiting neointima and extending vein graft patency.

Footnotes

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 04, 2019.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation
Mengxue Zhang, Bowen Wang, Go Urabe, Yitao Huang, Jorge Plutzky, K. Craig Kent, Lian-Wang Guo
bioRxiv 509414; doi: https://doi.org/10.1101/509414
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation
Mengxue Zhang, Bowen Wang, Go Urabe, Yitao Huang, Jorge Plutzky, K. Craig Kent, Lian-Wang Guo
bioRxiv 509414; doi: https://doi.org/10.1101/509414

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4672)
  • Biochemistry (10336)
  • Bioengineering (7655)
  • Bioinformatics (26284)
  • Biophysics (13497)
  • Cancer Biology (10664)
  • Cell Biology (15408)
  • Clinical Trials (138)
  • Developmental Biology (8485)
  • Ecology (12802)
  • Epidemiology (2067)
  • Evolutionary Biology (16819)
  • Genetics (11380)
  • Genomics (15458)
  • Immunology (10593)
  • Microbiology (25164)
  • Molecular Biology (10197)
  • Neuroscience (54381)
  • Paleontology (399)
  • Pathology (1664)
  • Pharmacology and Toxicology (2889)
  • Physiology (4332)
  • Plant Biology (9223)
  • Scientific Communication and Education (1585)
  • Synthetic Biology (2554)
  • Systems Biology (6769)
  • Zoology (1459)